세계의 유체 관리 시스템 시장 : 제품별, 용도별, 최종사용자별, 지역별 - 예측(-2030년)

The fluid management systems market is projected to reach USD 18.60 billion by 2030 from USD 13.26 billion in 2025, at a CAGR of 7.0% during the forecast period.

The fluid management systems (FMS) market is driven by several factors, including the increasing number of surgical procedures, a rising demand for minimally invasive techniques, and the growing incidence of chronic kidney and urological disorders. Technological advancements, such as automated suction and irrigation systems, enhance efficiency and safety, leading to wider adoption in healthcare facilities.

However, challenges such as high procedural costs and limited awareness in emerging regions can hinder growth. There are significant opportunities for expansion in the Asia Pacific region and for innovative developments in disposable and integrated systems that can improve accessibility and affordability.

The integrated systems segment is expected to register the highest CAGR during the forecast period.

By type, integrated systems are projected to experience the highest growth rate during the forecast period. This can be attributed to their ability to streamline surgical procedures, reduce setup time, and enhance operational efficiency. Additionally, their growing adoption in minimally invasive surgeries and the preference for compact, all-in-one solutions are further driving market expansion on a global scale.

The hospitals segment is expected to register the highest CAGR during the forecast period.

By end user, hospitals are expected to experience the highest growth rate in the fluid management systems market during the forecast period. This growth is driven by an increase in surgical volumes, advancements in healthcare infrastructure, and a rising adoption of minimally invasive procedures. As a result, hospitals are positioned as the primary end users of advanced fluid management technologies.

The Asia Pacific is expected to register the highest CAGR during the forecast period.

The Asia Pacific region is expected to experience the highest growth rate in the fluid management systems (FMS) market during the forecast period. This surge is primarily driven by the rapid expansion of healthcare infrastructure, increased government investments in modernizing hospitals, and a rise in chronic kidney and urological diseases. The growing adoption of minimally invasive surgeries and the increase in medical tourism in countries such as India, China, and Thailand also contribute to the demand for these systems. Additionally, supportive regulatory reforms and heightened awareness of advanced surgical technologies further enhance market expansion in this region.

A breakdown of the primary participants (supply side) for the fluid management systems market referred to in this report is provided below:

• By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
• By Designation: C-level Executives (42%), Director-level Executives (29%), and Others (29%)
• By Region: North America (29%), Europe (24%), Asia Pacific (29%), Latin America (10%), the Middle East & Africa (5%), and GCC Countries (3%)

Prominent players in the fluid management systems market are Fresenius Medical Care AG (Germany), Smith & Nephew Plc (UK), B. Braun SE (Germany), Stryker (US), Ecolab (US), CONMED Corporation (US), Cardinal Health (US), Olympus Corporation (Japan), ICU Medical (US), Zimmer Biomet Holdings, Inc. (US), Medtronic (Ireland), Hologic, Inc. (US), Johnson & Johnson (US), Baxter (Vantive) (US), and Nipro (Japan), among others.

Research Coverage

The report assesses the fluid management systems market, estimating its size and growth potential based on various segments, including products, applications, end users, and regions. Additionally, the report features a competitive analysis of the major players in this market, which includes company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will provide valuable data on revenue estimates for the overall fluid management systems market and its subsegments, benefiting both market leaders and new entrants. It will help stakeholders grasp the competitive landscape and gain insights for better positioning their businesses and developing effective go-to-market strategies. Additionally, the report offers an understanding of market trends, highlighting key drivers, obstacles, and opportunities within the industry.

This report provides insights into the following points:

• Analysis of key drivers (rising number of minimally invasive surgeries, increasing ESRD patient base, technological advancements in fluid management systems, government funds and grants for endosurgical procedures, and rising number of hospitals and investments in endoscopy and laparoscopy facilities), restraints (high cost of endosurgical procedures and lack of consumer awareness), opportunities (untapped potential in emerging markets and single-use disposable devices and accessories), and challenges (dearth of surgeons worldwide)
• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global fluid management systems market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global fluid management systems market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global fluid management systems market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.2.2 MARKETS COVERED
  • 1.2.3 YEARS CONSIDERED
  • 1.2.4 CURRENCY CONSIDERED
• 1.3 MARKET STAKEHOLDERS
• 1.4 LIMITATIONS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 METHODOLOGY-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 FLUID MANAGEMENT SYSTEMS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: FLUID MANAGEMENT SYSTEMS MARKET, BY PRODUCT & COUNTRY (2024)
• 4.3 FLUID MANAGEMENT SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 FLUID MANAGEMENT SYSTEMS MARKET, REGIONAL MIX, 2023-2030
• 4.5 FLUID MANAGEMENT SYSTEMS MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising number of minimally invasive surgeries
    • 5.2.1.2 Increasing prevalence of ESRD
    • 5.2.1.3 Technological advancements in fluid management systems
    • 5.2.1.4 Government funds & grants for endosurgical procedures
    • 5.2.1.5 Rising establishment of endoscopy & laparoscopy facilities in hospitals
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of endosurgical procedures
    • 5.2.2.2 Lack of consumer & patient awareness
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High growth potential of emerging economies
    • 5.2.3.2 Single-use disposable devices & accessories
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of surgeons
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2024 (USD)
  • 5.4.2 AVERAGE SELLING PRICE TREND OF INTEGRATED FLUID MANAGEMENT SYSTEMS, BY REGION, 2022-2024 (USD)
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT & FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Irrigation/Distension pumps & disposable cassettes
    • 5.9.1.2 Closed fluid waste capture & automated transfer
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 OR/Endoscopy integration, traceability, and connectivity
    • 5.9.2.2 Procedure-specific sterile kits & modular disposables
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Hemodynamic monitoring & decision support
    • 5.9.3.2 Renal support & critical-care circuits (CRRT/Dialysis/ECMO)
• 5.10 INDUSTRY TRENDS
  • 5.10.1 GRADUAL SHIFT TO CLOSED-LOOP & HANDS-FREE WASTE SYSTEMS
  • 5.10.2 DIGITIZATION, TRACEABILITY, AND CONNECTIVITY
• 5.11 PATENT ANALYSIS
• 5.12 TRADE ANALYSIS
  • 5.12.1 IMPORT DATA (HS CODE 901890)
  • 5.12.2 EXPORT DATA (HS CODE 901890)
• 5.13 KEY CONFERENCES & EVENTS, 2025-2026
• 5.14 CASE STUDY ANALYSIS
  • 5.14.1 CASE STUDY 1: CLOSED FLUID WASTE MANAGEMENT SYSTEM (STRYKER'S NEPTUNE)-SAFER & FASTER OPERATING ROOM TURNOVERS
  • 5.14.2 CASE STUDY 2: FLUID WARMING SYSTEMS-REDUCING PERIOPERATIVE HYPOTHERMIA
  • 5.14.3 CASE STUDY 3: HEIDELBERG ENGINEERING-NHS UK OCT DEPLOYMENT
• 5.15 REGULATORY ANALYSIS
  • 5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.15.2 REGULATORY FRAMEWORK
    • 5.15.2.1 North America
      • 5.15.2.1.1 US
      • 5.15.2.1.2 Canada
    • 5.15.2.2 Europe
      • 5.15.2.2.1 Germany
      • 5.15.2.2.2 France
      • 5.15.2.2.3 UK
    • 5.15.2.3 Asia Pacific
      • 5.15.2.3.1 India
      • 5.15.2.3.2 China
      • 5.15.2.3.3 Japan
    • 5.15.2.4 Latin America
      • 5.15.2.4.1 Brazil
      • 5.15.2.4.2 Mexico
    • 5.15.2.5 Middle East & Africa
      • 5.15.2.5.1 Middle East
      • 5.15.2.5.2 Africa
• 5.16 PORTER'S FIVE FORCES ANALYSIS
  • 5.16.1 BARGAINING POWER OF SUPPLIERS
  • 5.16.2 BARGAINING POWER OF BUYERS
  • 5.16.3 THREAT OF NEW ENTRANTS
  • 5.16.4 THREAT OF SUBSTITUTES
  • 5.16.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.17.2 BUYING CRITERIA
• 5.18 IMPACT OF AI/GENERATIVE AI ON FLUID MANAGEMENT SYSTEMS MARKET
  • 5.18.1 AI-USE CASES
  • 5.18.2 KEY COMPANIES IMPLEMENTING AI
  • 5.18.3 FUTURE OF AI/GEN AI
• 5.19 ADJACENT MARKET ANALYSIS
• 5.20 TRUMP TARIFF IMPACT ON FLUID MANAGEMENT SYSTEMS MARKET
  • 5.20.1 KEY TARIFF RATES
  • 5.20.2 PRICE IMPACT ANALYSIS
  • 5.20.3 KEY IMPACT ON COUNTRY/REGION
    • 5.20.3.1 US
    • 5.20.3.2 Europe
    • 5.20.3.3 Asia Pacific
  • 5.20.4 IMPACT ON END-USER INDUSTRIES

6 FLUID MANAGEMENT SYSTEMS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 SYSTEMS
  • 6.2.1 STANDALONE SYSTEMS
    • 6.2.1.1 Dialyzers
      • 6.2.1.1.1 Rising CKD and ESRD cases globally to fuel consistent demand for dialyzers in fluid management systems
    • 6.2.1.2 Insufflators
      • 6.2.1.2.1 Growing adoption of minimally invasive surgeries to drive demand for insufflators
    • 6.2.1.3 Suction/Evacuation & irrigation systems
      • 6.2.1.3.1 Critical role of these systems in ensuring surgical precision to boost demand
    • 6.2.1.4 Fluid waste management systems
      • 6.2.1.4.1 Reduced risk of cross-contamination and exposure to biohazardous waste to drive adoption
    • 6.2.1.5 Other standalone systems
  • 6.2.2 INTEGRATED SYSTEMS
    • 6.2.2.1 Growing need for accurate and efficient fluid management to support market growth
• 6.3 DISPOSABLES & ACCESSORIES
  • 6.3.1 CATHETERS
    • 6.3.1.1 Recurring demand for single-use catheters to support sustained revenue growth in market
  • 6.3.2 BLOODLINES
    • 6.3.2.1 Advancements in bloodline design and safety to fuel segment growth
  • 6.3.3 TUBING SETS
    • 6.3.3.1 Increasing patient safety awareness to accelerate demand for sterile tubing sets in hospitals and clinics
  • 6.3.4 PRESSURE MONITORING LINES
    • 6.3.4.1 Technological advancements in monitoring devices to enhance utility of pressure monitoring lines in critical care
  • 6.3.5 PRESSURE TRANSDUCERS
    • 6.3.5.1 Increasing patient safety awareness to accelerate demand in hospitals and clinics
  • 6.3.6 VALVES, CONNECTORS, AND FITTINGS
    • 6.3.6.1 Increased focus on infection prevention to boost market
  • 6.3.7 SUCTION CANISTERS
    • 6.3.7.1 Disposable suction canisters to gain traction due to stricter infection control and contamination prevention protocols
  • 6.3.8 CANNULAS
    • 6.3.8.1 Expanding chronic disease treatments to boost cannula utilization in fluid management applications
  • 6.3.9 OTHER DISPOSABLES & ACCESSORIES

7 FLUID MANAGEMENT SYSTEMS MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 UROLOGY & NEPHROLOGY
  • 7.2.1 INCREASING PREVALENCE OF CKD AND ESRD TO DRIVE MARKET GROWTH
• 7.3 GASTROENTEROLOGY
  • 7.3.1 EXPANDING ENDOSCOPY CENTERS IN BOTH DEVELOPED AND EMERGING ECONOMIES TO SUPPORT GROWTH
• 7.4 GENERAL SURGERY
  • 7.4.1 TECHNOLOGICAL INNOVATIONS IN SURGICAL EQUIPMENT TO FUEL ADOPTION
• 7.5 ORTHOPEDICS
  • 7.5.1 GROWING NUMBER OF SPECIALIZED ORTHOPEDIC CENTERS TO FUEL GROWTH
• 7.6 GYNECOLOGY
  • 7.6.1 STRONG DEMAND FOR RELIABLE FLUID REGULATION TECHNOLOGIES TO SUPPORT MARKET GROWTH
• 7.7 CARDIOVASCULAR SURGERY
  • 7.7.1 ABILITY OF FLUID MANAGEMENT SYSTEMS TO ENSURE STABLE HEMODYNAMICS AND MINIMIZE BLOOD LOSS TO DRIVE GROWTH
• 7.8 NEUROSURGERY
  • 7.8.1 ADVANCEMENTS IN NEURO-ENDOSCOPY AND IMAGE-GUIDED SURGERIES TO PROPEL MARKET GROWTH
• 7.9 ENT
  • 7.9.1 INCREASING PREVALENCE OF ENT DISORDERS TO SUPPORT GROWTH
• 7.10 OTHER APPLICATIONS

8 FLUID MANAGEMENT SYSTEMS MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS
  • 8.2.1 ADVANCED INFRASTRUCTURE, SPECIALIZED OPERATING ROOMS, AND HIGHLY SKILLED MEDICAL PROFESSIONALS TO BOOST MARKET
• 8.3 DIALYSIS CENTERS
  • 8.3.1 INCREASING NUMBER OF PATIENTS REQUIRING LONG-TERM DIALYSIS CARE TO EXPAND MARKET
• 8.4 AMBULATORY SURGICAL CENTERS
  • 8.4.1 RISING PREFERENCE FOR OUTPATIENT SURGERIES TO BOOST GROWTH
• 8.5 OTHER END USERS

9 FLUID MANAGEMENT SYSTEMS MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 Growing ASC migration and OSHA compliance to accelerate adoption of fluid management systems
  • 9.2.3 CANADA
    • 9.2.3.1 Growing biosafety requirements to boost adoption of standardized, closed-loop fluid handling consumables nationwide
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Multi-year public tenders and regional procurement structures to drive uniform adoption of closed-loop fluid handling systems
  • 9.3.3 FRANCE
    • 9.3.3.1 High procedure throughput, rapid ambulatory adoption, and codified biosafety rules to support market growth
  • 9.3.4 UK
    • 9.3.4.1 High NHS funding and sustained diagnostic capacity build-out to boost growth
  • 9.3.5 ITALY
    • 9.3.5.1 Large hospital network and steadily aging population to contribute to market growth
  • 9.3.6 SPAIN
    • 9.3.6.1 High hospital throughput and codified exposure-control expectations to propel market
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Aging demographics and high exam/surgery capacity to boost market
  • 9.4.3 CHINA
    • 9.4.3.1 Large care volumes, dense hospital infrastructure, and broad insurance coverage to support growth
  • 9.4.4 INDIA
    • 9.4.4.1 High prevalence of diabetes and increasing awareness about eye health to fuel market
  • 9.4.5 SOUTH KOREA
    • 9.4.5.1 Universal coverage and high endoscopy throughput to drive market growth
  • 9.4.6 AUSTRALIA
    • 9.4.6.1 High caseloads and mixed public-private hospital base to propel growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Large inpatient volumes and critical care capacity to aid growth
  • 9.5.3 MEXICO
    • 9.5.3.1 Expanding insured base in Mexico to boost adoption
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 ESTABLISHED SAFETY STANDARDS TO DRIVE ADOPTION OF FLUID MANAGEMENT SYSTEMS
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 9.7 GCC COUNTRIES
  • 9.7.1 GROWING NUMBER OF FORMAL PROCUREMENT PROGRAMS ACROSS PUBLIC AND PRIVATE HEALTHCARE PROVIDERS TO FUEL GROWTH
  • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN FLUID MANAGEMENT SYSTEMS MARKET
• 10.3 REVENUE ANALYSIS
• 10.4 MARKET SHARE ANALYSIS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Product footprint
    • 10.5.5.4 Application footprint
    • 10.5.5.5 End-user footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 10.6.5.1 Detailed list of key startups/SMEs
    • 10.6.5.2 Competitive benchmarking of startups/SMEs
• 10.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.7.1 FINANCIAL METRICS
  • 10.7.2 COMPANY VALUATION
• 10.8 BRAND/PRODUCT COMPARISON
  • 10.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT ENHANCEMENTS
  • 10.9.2 DEALS

11 COMPANY PROFILE

• 11.1 KEY PLAYERS
  • 11.1.1 FRESENIUS MEDICAL CARE AG
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product enhancements
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 CARDINAL HEALTH
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Other developments
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 BAXTER INTERNATIONAL INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 MnM view
      • 11.1.3.3.1 Key strengths
      • 11.1.3.3.2 Strategic choices
      • 11.1.3.3.3 Weaknesses & competitive threats
  • 11.1.4 OLYMPUS CORPORATION
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 MnM view
      • 11.1.4.3.1 Key strengths
      • 11.1.4.3.2 Strategic choices
      • 11.1.4.3.3 Weaknesses & competitive threats
  • 11.1.5 B. BRAUN SE
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Other developments
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Key strengths
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 STRYKER
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
  • 11.1.7 MEDTRONIC
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Other developments
  • 11.1.8 JOHNSON & JOHNSON
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
  • 11.1.9 SMITH & NEPHEW PLC
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 NIPRO CORPORATION
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
  • 11.1.11 CONMED CORPORATION
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
  • 11.1.12 ECOLAB INC.
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
  • 11.1.13 HOLOGIC, INC.
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 ZIMMER BIOMET HOLDINGS, INC.
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
  • 11.1.15 ICU MEDICAL, INC.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 KARL STORZ GMBH & CO. KG
  • 11.2.2 ACTEON MEDICAL
  • 11.2.3 MEDLINE INDUSTRIES, LP
  • 11.2.4 DEROYAL INDUSTRIES, INC.
  • 11.2.5 MOLNLYCKE HEALTH CARE AB
  • 11.2.6 TIANJIN ZHICHAO MEDICAL TECHNOLOGY CO., LTD.
  • 11.2.7 HUNAN HONYMED CO., LTD.
  • 11.2.8 SCIVITA MEDICAL
  • 11.2.9 HANGZHOU VALUED MEDTECH CO., LTD.
  • 11.2.10 SERENNO MEDICAL

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS